FEP Testosterone–Injection & Implant Medical Review Request

Loading...

Loading...

  • Required *

  • Enter Patient Information

  • Diagnosis Codes must be 3-8 characters along with decimals

    Codes must be 3 - 8 characters and 2 decimals.
  • Yes No
  • Required *

  • Enter Provider Information

  • Enter a 10 digit phone number.
  • Enter a 10 digit phone number.
  • For requests for Aveed, has the prescriber been certified by the Aveed REMS program?

    • Yes
    • No *
  • 1. Will the patient be using this medication in combination with any other form of testosterone?

    • Yes
    • No *
  • 2. Please answer the following questions based on the patient’s diagnosis.

    • Inoperable metastatic breast cancer OR   
    • Inoperable metastatic mammary cancer
    1. If initiating testosterone therapy, has the patient received at least one prior therapy for treatment of this condition?
      • Yes
      • No *
    2. Will the patient be monitored for hypercalcemia every 6 months and advised to discontinue testosterone if found to be present?
      • Yes
      • No *
    3. Will the liver function tests and hematocrit level be monitored every 6 months?
      • Yes
      • No *
    • Delay in sexual development and/or puberty
    1. Will the patient’s bone age of the hand and wrist be assessed every 6 months as determined by radiographic evidence?
      • Yes
      • No *
    2. Will the liver function tests and hematocrit level be monitored every 6 months?
      • Yes
      • No *
    Deficiency of testosterone/hypogonadism (attach lab values)
      1. Choose a file or files to attach (File types accepted: jpg, txt, doc, docx, pdf, xls, xlsx, ppt, pptx, rtf, tiff, and tif)

        To upload multiple files, hold down the CTRL key while selecting multiple documents then click open.







      • Has the patient been on testosterone therapy in any dosage form continuously for the last 4 months (excluding samples)?

        NO – this would be the INITIATION of Testosterone therapy, please answer the following questions:
        1. Has the patient had two morning total testosterone levels less than 300 ng/dL on different days?
          • Yes
          • No *
        2. What is the patient’s hematocrit level?
          %
        3. For patients >40 years of age: Does the patient have a baseline PSA level < 4 ng/ml?
          • Yes
          • No
          • N/A - patient had a prostatectomy *
        4. Does the patient have current diagnosis of prostate cancer and/or palpable prostate nodules?
          • Yes
          • No *
        5. Does the patient have a concurrent diagnosis of benign prostate hyperplasia (BPH)?
          • Yes
          • No *
          • * IF YES, will the symptoms associaed with BPH be monitored for worsening symptoms?
            • Yes
            • No *
        6. Has the prescribing physician assessed the patient for their cardiovascular risk for myocardial infarction (MI), angina, and stroke?
          • Yes
          • No *
        7. Does the patient have a diagnosis of sleep apnea?
          • Yes
          • No *
          • * IF YES, is the patient being treated for their sleep apnea?
            • Yes
            • No *
      • Yes - this would be the CONTINUATION of therapy, please answer the following questions:
        1. Does the patient have a total testosterone level 800 ng/dL or less?
          • Yes
          • No *
        2. If the patient has BPH, have the patient’s symptoms worsened?
          • Yes
          • No
          • N/A - patient does not have BPH *
        3. Has the prescribing physician re-assessed the patient for their cardiovascular risk for myocardial infarction (MI), angina, and stroke?
          • Yes
          • No *
        4. Will the following be monitored every 12 months:
          • Serum testosterone concentrations
            • Yes
            • No *
          • Hematocrit levels
            • Yes
            • No *
          • For patients >40 years of age: Prostate specific antigen (PSA)
            • Yes
            • No
            • N/A - patient had a prostatectomy *
    • Gender Dysphoria (GD)
      1. Is the patient undergoing a female to male transition?
        • Yes
        • No *
      2. Is this medication being prescribed by an endocrinologist?
        • Yes
        • No *
      3. Has the patient met the DSM-5 criteria for Gender Dysphoria?
        • Yes
        • No *

If you have any additional information pertinent to this patient’s therapy, please specify.

  • Checking this box will send a copy of your form to the email address provided.

If you experience issues submitting this form, please try again later.

Or, print the form and mail to:

Blue Cross and Blue Shield of Kansas City
Pharmacy Services
P.O. Box 412735
Kansas City, MO 64141-2735

Cancel
Member Prefix

Your prefix is on the front of your Member ID card. See the sample ID card above. If you do not have your member ID card, contact the Customer Service department by clicking Contact Us, or calling 816-395-3558 or 888-989-8842.

IMPORTANT: If you are an FEP Member, enter "NA" into the Prefix field.

ID Number

Your member ID is a unique number that identifies your plan. It is on the front of your Member ID card. See the sample ID card above. If you do not have your member ID card, contact the Customer Service department by clicking Contact Us, or calling 816-395-3558 or 888-989-8842.

Suffix

Your Suffix is a two digit number located on your Member ID card. See the sample ID card above. If you do not have your member ID card, contact the Customer Service department by clicking Contact Us, or calling 816-395-3558 or 888-989-8842.

For Blue Card members, suffix is not required.